Despite being the largest study of BDG measurement in ARF, results from analyses for subgroups (e.g., longitudinal sample analyses) and specific biomarkers (e.g., FABP-2) require cautious interpretation because the effective sample size for certain analyses was smaller. Here, FABP2 is linked to acute kidney injury.